OurCrowd

JANUARY 13, 2021

The post [DarioHealth in PR Newswire] Diabetes and Behavioral Health Global Experts Join DarioHealth Scientific Advisory Board Expanding Innovation Leadership in Digital Therapeutics for Chronic Care D appeared first on OurCrowd Blog. Read more here.

digital therapeutics 28

digital therapeutics leadership board health 28

OurCrowd

NOVEMBER 16, 2022

16, 2022 Sweetch, a digital therapeutics innovator and creator of the precision engagement platform for chronic conditions, announced today that Fatima Cody Stanford MD, MPH, MPA, MBA, FAAP, FACP, FAHA, FAMWA, FTOS has joined the company as an advisor. TEL AVIV, Israel, Nov. Read more on PR Newswire here.

digital therapeutics 36

digital therapeutics board innovation hospitality 36

OurCrowd

APRIL 26, 2022

TEL AVIV, Israel, April 26, 2022 /PRNewswire/ — Sweetch, a digital therapeutics innovator and creator of the precision engagement platform for chronic conditions, announced today that Robert A. The post [Sweetch in PR Newswire] Sweetch Strengthens its Advisory Board with Appointment of Diabetes Care Leader, Dr. Robert A.

digital therapeutics 36

digital therapeutics board innovation 36

HPA

MARCH 15, 2022

We’re excited to share that metaMe Health , a prescription digital therapeutics (PDT) company, today announced raising $2.2M Ken Greisman , the HPA Deal Lead and a veteran of the pharmaceutical industry, has joined the metaMe board of directors. in funding. and chief legal officer at Takeda Pharmaceuticals U.S.A.,

health 113

health digital therapeutics board support 113

HPA

MARCH 15, 2022

We’re excited to share that metaMe Health , a prescription digital therapeutics (PDT) company, today announced raising $2.2M Ken Greisman , the HPA Deal Lead and a veteran of the pharmaceutical industry, has joined the metaMe board of directors. in funding. and chief legal officer at Takeda Pharmaceuticals U.S.A.,

health 91

health digital therapeutics board support 91

AsiaTechDaily

APRIL 30, 2022

Register Biofourmis , a Sigapore-founded digital therapeutics firm , announced that it has surpassed unicorn status with a $300 million Series D investment led by leading global growth equity firm General Atlantic. Bookmark ( 0 ) Please login to bookmark Username or Email Address Password Remember Me No account yet?

digital therapeutics 52

digital therapeutics health accelerator board 52

Angel Capital Association

MAY 18, 2020

MedRhythms, a Portland, Maine-based digital therapeutics company, is building direct stimulation, prescription therapeutics that use sensors, music, and software to improve loss of mobility caused by neurologic injuries and diseases. How does MedRhythms’ technology work?

digital therapeutics 40

digital therapeutics hospitality angel capital economic development 40